Chetan Rathi

Chetan Rathi

GlaxoSmithKline - Needham / United Kingdom
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4370408
-
person_outline Chetan Rathi's MOST POPULAR ARTICLES
1-) Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studiesRS Bhatta, H Chandasana, YS Chhonker, C Rathi, D Kumar, K Mitra, ...International journal of pharmaceutics 432 (1-2), 105-112, 20121962012
2-) Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug effluxRE Lee, JG Hurdle, J Liu, DF Bruhn, T Matt, MS Scherman, PK Vaddady, ...Nature medicine 20 (2), 152-158, 20141582014
3-) Clinical pharmacology of bispecific antibody constructsC Rathi, B MeibohmThe Journal of Clinical Pharmacology 55 (S3), S21-S28, 2015362015
4-) Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumorsAB El-Khoueiry, J Clarke, T Neff, T Crossman, N Ratia, C Rathi, P Noto, ...British journal of cancer 129 (2), 309-317, 2023472023
5-) Translational PK/PD of anti-infective therapeuticsC Rathi, RE Lee, B MeibohmDrug Discovery Today: Technologies 21, 41-49, 2016382016